Beam Therapeutics Inc. Common Stock (NASDAQ: BEAM) last traded at $29.76, up 4.83% on the session. The quote above updates while this page is open; the figures below are drawn from Beam Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Beam Therapeutics Inc. Common Stock trades on NASDAQ under the ticker BEAM. Its market capitalisation is $3.07 billion.
Valuation measures for Beam Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.07B |
|---|---|
| Enterprise value | $3.17B |
| Price / sales | 19.70 |
| Price / book | 2.88 |
| Beta | 2.10 |
Trailing-twelve-month figures tagged in Beam Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $156.03M |
|---|---|
| Net income (TTM) | -$86.52M |
| EPS (TTM) | -$0.670 |
| Operating margin | -242.27% |
| Return on equity | -8.11% |
| Cash | $219.82M |
Range and volume for BEAM over the past 52 weeks.
| 52-week high | $38.26 |
|---|---|
| 52-week low | $16.02 |
| Volume | 2.45M |
| Average volume | 2.17M |
| Previous close | $28.39 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.